Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Gains from Investment Securities: 2014-2022

Historic Gains from Investment Securities for Wave Life Sciences (WVE) over the last 7 years, with Dec 2022 value amounting to $12.0 million.

  • Wave Life Sciences' Gains from Investment Securities rose 25510.00% to $2.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $7.5 million, marking a year-over-year increase of 1725.87%. This contributed to the annual value of $12.0 million for FY2022, which is 166.92% up from last year.
  • Wave Life Sciences' Gains from Investment Securities amounted to $12.0 million in FY2022, which was up 166.92% from $4.5 million recorded in FY2021.
  • Over the past 5 years, Wave Life Sciences' Gains from Investment Securities peaked at $12.0 million during FY2022, and registered a low of -$44,000 during FY2018.
  • In the last 2 years, Wave Life Sciences' Gains from Investment Securities had a median value of $8.3 million in 2021 and averaged $8.3 million.
  • Data for Wave Life Sciences' Gains from Investment Securities shows a peak YoY skyrocketed of 166.92% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Wave Life Sciences' Gains from Investment Securities stood at -$44,000 in 2018, then reached $4.5 million in 2021, then spiked by 166.92% to $12.0 million in 2022.